Recently, CFX has become the focus of the market due to the news that Pioneer Pharmaceutical Biotechnology Company intends to acquire the company. This potential transaction not only highlights CFX's position as a leader in the domestic public chain but also injects new momentum from the Hong Kong concept, attracting widespread attention from investors.

However, regarding the investment prospects of CFX, we need to maintain a clear and cautious attitude. Although there may be speculative opportunities in the short term, the historical trend of CFX indicates that there is considerable selling pressure on the upside, along with a large amount of historical stuck positions. More importantly, the project team has previously exhibited a pattern of rapid surges followed by sharp declines, which undoubtedly increases investment risk.

For investors interested in participating in CFX trading, we recommend focusing on the opportunities brought about by the news fermentation in the short term. Consider timing your high sell and quick entry during the expected speculation period, but be cautious and avoid chasing highs. This strategy is suitable for experienced traders, while novice investors should remain vigilant and avoid holding for the long term.

Overall, CFX is currently more suitable as a target for short-term speculation rather than a long-term investment. Investors should always follow market dynamics, weigh risks and returns, and make informed investment decisions. In this rapidly changing market, maintaining rationality and flexibility is crucial.